MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 180 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $482,508 | +6.3% | 14,529 | +0.9% | 0.01% | 0.0% |
Q3 2022 | $454,000 | +4.4% | 14,406 | +0.6% | 0.01% | -14.3% |
Q2 2022 | $435,000 | +2.4% | 14,314 | -12.5% | 0.01% | +75.0% |
Q1 2022 | $425,000 | +25.0% | 16,353 | -1.8% | 0.00% | 0.0% |
Q4 2021 | $340,000 | +1.2% | 16,653 | -4.6% | 0.00% | 0.0% |
Q3 2021 | $336,000 | -13.6% | 17,453 | -0.6% | 0.00% | 0.0% |
Q2 2021 | $389,000 | -15.6% | 17,553 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $461,000 | +43.2% | 17,553 | +1.7% | 0.01% | +25.0% |
Q4 2020 | $322,000 | +8.1% | 17,253 | -1.5% | 0.00% | 0.0% |
Q3 2020 | $298,000 | -24.7% | 17,523 | +2.9% | 0.00% | -33.3% |
Q2 2020 | $396,000 | +176.9% | 17,023 | 0.0% | 0.01% | +200.0% |
Q1 2020 | $143,000 | -13.9% | 17,023 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $166,000 | +2.5% | 17,023 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $162,000 | -18.6% | 17,023 | +1.8% | 0.00% | -33.3% |
Q2 2019 | $199,000 | -31.1% | 16,723 | +1.8% | 0.00% | -25.0% |
Q1 2019 | $289,000 | +3.2% | 16,423 | +1.8% | 0.00% | 0.0% |
Q4 2018 | $280,000 | – | 16,126 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Acuitas Investments, LLC | 283,983 | $6,299,000 | 3.15% |
Euclidean Technologies Management, LLC | 128,088 | $2,841,000 | 2.26% |
GLOBEFLEX CAPITAL L P | 185,939 | $4,124,000 | 0.74% |
HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,194,000 | 0.66% |
CLARK ESTATES INC/NY | 220,000 | $4,880,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,424,274 | $31,590,000 | 0.56% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 789,827 | $17,518,000 | 0.53% |
EARNEST PARTNERS LLC | 3,885,748 | $86,186,000 | 0.51% |
MOODY ALDRICH PARTNERS LLC | 137,075 | $3,040,000 | 0.43% |
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 414,323 | $9,190,000 | 0.33% |